This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
SolarWinds (SWI) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
SolarWinds (SWI) delivered earnings and revenue surprises of 8% and 3.06%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
ETWO or PYCR: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ETWO vs. PYCR: Which Stock Is the Better Value Option?
Paycor HCM, Inc. (PYCR) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Paycor HCM (PYCR) delivered earnings and revenue surprises of 22.22% and 2.31%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Unity Software Inc. (U) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Unity Software (U) delivered earnings and revenue surprises of 27.27% and 3.65%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Bentley Systems, Incorporated (BSY) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Bentley Systems (BSY) delivered earnings and revenue surprises of 29.17% and 1.62%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Appian (APPN) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Appian (APPN) delivered earnings and revenue surprises of 16.13% and 3.09%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Skyworks Solutions (SWKS) Q3 Earnings Match Estimates
by Zacks Equity Research
Skyworks (SWKS) delivered earnings and revenue surprises of 0% and 0.54%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
ALIT or PYCR: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ALIT vs. PYCR: Which Stock Is the Better Value Option?
Paycor HCM, Inc. (PYCR) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Paycor HCM (PYCR) delivered earnings and revenue surprises of 5% and 0.36%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
STNE vs. PYCR: Which Stock Is the Better Value Option?
by Zacks Equity Research
STNE vs. PYCR: Which Stock Is the Better Value Option?
Calix (CALX) Tops Q1 Earnings Estimates
by Zacks Equity Research
Calix (CALX) delivered earnings and revenue surprises of 5% and 0.74%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
ALIT vs. PYCR: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
ALIT vs. PYCR: Which Stock Is the Better Value Option?
ALIT or PYCR: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ALIT vs. PYCR: Which Stock Is the Better Value Option?
CS Disco (LAW) Moves 8.7% Higher: Will This Strength Last?
by Zacks Equity Research
CS Disco (LAW) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Paycor HCM, Inc. (PYCR) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Paycor HCM, Inc. (PYCR) delivered earnings and revenue surprises of 22.22% and 2.61%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Earnings Estimates Moving Higher for Paycor HCM, Inc. (PYCR): Time to Buy?
by Zacks Equity Research
Paycor HCM, Inc. (PYCR) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Wall Street Analysts See a 26.24% Upside in Paycor HCM, Inc. (PYCR): Can the Stock Really Move This High?
by Zacks Equity Research
The mean of analysts' price targets for Paycor HCM, Inc. (PYCR) points to a 26.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
ZM or PYCR: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ZM vs. PYCR: Which Stock Is the Better Value Option?
Paycor HCM, Inc. (PYCR) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Paycor HCM, Inc. (PYCR) delivered earnings and revenue surprises of 33.33% and 2.62%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
D-Wave Quantum Inc. (QBTS) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
D-Wave Quantum Inc. (QBTS) delivered earnings and revenue surprises of -7.69% and 5.17%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Nextdoor Holdings, Inc. (KIND) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Nextdoor Holdings, Inc. (KIND) delivered earnings and revenue surprises of 10% and 5.92%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
New Strong Buy Stocks for May 11th
by Zacks Equity Research
AMEH, PYCR, AWH, SAND and MCD have been added to the Zacks Rank #1 (Strong Buy) List on May 11, 2023.
Paycor HCM, Inc. (PYCR) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Paycor HCM, Inc. (PYCR) delivered earnings and revenue surprises of 20% and 3.46%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
KORE Group Holdings, Inc. (KORE) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
KORE Group Holdings, Inc. (KORE) delivered earnings and revenue surprises of -81.82% and 1.16%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Waters (WAT) Q1 Earnings & Sales Miss Estimates, Down Y/Y
by Zacks Equity Research
Waters' (WAT) first-quarter results reflect softness in the pharmaceutical market and a slowdown in instruments sales.